All
Results: 34453-34464 of 62949

ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

Singapore Hosts Delegation Led by President and Chief Justice of Supreme People's Court of the People's Republic of China for Eighth Singapore-China Legal and Judicial Roundtable

Xinhua Silk Road: Annual Conference of Financial Street Forum 2024 brings attention to China's financial opening-up, cooperation for economic stability







